We are thrilled to announce that QDOSE, the predecessor of QDSOE+, has achieved a significant milestone – receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance underscores our commitment to delivering safe and effective solutions to the theranostic community.
Join us in celebrating this milestone! Feel free to ask questions, leave comments, and learn more about how QDOSE is set to make a positive impact in improving patient care.
Thank you, everyone, for your hard work and dedication in making this achievement possible.